For any additional information please contact us directly:
Dr. Christopher Große
Tel.: +49 89 998421-0
Fax: +49 89 998421-11
Publication of inside information pursuant to Art. 17 MAR
Munich, April 24, 2019 – The Supervisory Board of Allgeier SE (ISIN DE000A2GS633, WKN A2GS63) today approved the audited annual and consolidated financial statements of Allgeier SE for the 2018 financial year. The annual financial statements have thereby been adopted. The final consolidated figures essentially correspond to the preliminary figures announced in the ad hoc announcement of March 22, 2019.
IFRS revenue and earnings trends
In the 2018 financial year (01 January 2018 – 31 December 2018), the Group recorded double-digit growth in sales and value added. In 2018, Group sales rose by 19 percent year-on-year to EUR 688.0 million (previous year: EUR 577.0 million). Group value added rose by 24 percent to EUR 194.7 million (previous year: EUR 156.8 million). Adjusted Group EBITDA (EBITDA before effects classified as extraordinary or prior-period from a business perspective) rose by 38 percent to EUR 40.6 million (previous year: EUR 29.3 million). Group EBITDA (earnings before interest, taxes, depreciation and amortization) rose by 14 percent to EUR 30.3 million (previous year: EUR 26.5 million). Group EBIT (earnings before interest and taxes) for the period rose by 19 percent to EUR 16.0 million (previous year: EUR 13.5 million). In the period under review, the Group generated EBT (earnings before taxes) of 13.1 million Euro (previous year: 11.0 million Euro). Income tax expenses in the reporting period amounted to Euro 6.3 million (previous year: Euro 6.5 million). After taxes, the Group generated earnings for the period of Euro 6.9 million (previous year: Euro 4.5 million). From the sale of Allgeier Medical IT GmbH at the end of March 2018, the Group generated a capital gain of EUR 1.7 million. The total result for the period thus amounted to EUR 8.6 million (previous year: EUR 4.5 million). Operating earnings per share adjusted for amortization from acquisition activities and calculated with normalized taxes amounted to EUR 1.60 in the year under review (previous year: EUR 1.06).
Key balance sheet financials as of December 31, 2018
As of the December 31, 2018 reporting date, equity amounted to EUR 133.9 million (previous year: EUR 122.8 million). The Allgeier Group had liquid assets of EUR 77.0 million at its disposal as of the 2018 year-end (previous year: EUR 53.0 million). Current and non-current financial liabilities increased to EUR 181.7 million as of the reporting date (previous year: EUR 108.8 million). Total assets amounted to 480.4 million euros as of December 31, 2018 (December 31, 2017: 337.9 million euros).
Application of profits
The Supervisory Board has today, April 24, 2019, passed a resolution to propose to the Annual General Meeting to distribute a dividend of EUR 0.50 per share to the shareholders from the unappropriated net profit of EUR 16,588,280.41 as reported as of December 31, 2018 in the separate annual financial statements of Allgeier SE. The remaining balance sheet profit is to be carried forward to a new account.
Outlook for the 2019 financial year
The current planning for the 2019 financial year envisages Group revenue growth in the region of 15 to 20 percent with an EBITDA margin of between 6.5 and 7 percent. The forecast made in the ad hoc announcement of 22 March 2019 is maintained. The target figures relate exclusively to the organic development of the currently existing Group, including the companies acquired in 2018, without any further changes to the portfolio. Further acquisitions in the individual business segments can make an additional contribution to growth.
The Allgeier Annual Report 2018 will be published on April 30, 2019 and can then be viewed at www.allgeier.com All figures have been calculated in accordance with IFRS. The statements for the 2019 financial year represent future expectations based on the current planning, the occurrence of which cannot, however, be expected with certainty.